期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

类风湿性关节炎中破骨细胞基质金属蛋白酶9的研究进展 被引量：4

The Research Progress of Matrix Metalloproteinase-9 Secreted by Osteoclast in Rheumatoid Arthritis
下载PDF
导出
摘要 类风湿性关节炎骨质侵蚀与关节破坏是近年来研究的热点。目前,已经知道破骨细胞是导致关节侵蚀的主要细胞,而基质金属蛋白酶9(MMP-9)在破骨细胞中高表达,在细胞外间质的降解中发挥重要作用。破骨细胞分化过程中,MMP-9基因表达受到多种因素的调控。现将近几年MMP-9在类风湿性关节炎发生发展中的作用及其调控机制等予以综述。 Osseous erosion and joint damage in rheumatoid arthritis become an investigative hot spots in recent years. It is known that osteoclast is the main cell causing osseous erosion, while matrix metalloproteinase-9 highly expressed in osteoclast, plays an important role in extracellular matrix degradation. The gene expression of MMP-9 is regulated by several factors. This article reviewed the role of MMP-9 expression in osteoclast and its regulation mechanism in recent years.
作者 李萍 刘力 王文杰
机构地区 西南大学动物科技学院 中国医学科学院中国协和医科大学药物研究所
出处 《医学综述》 2008年第8期1127-1129,共3页 Medical Recapitulate
基金 国家"863"计划资助课题(2002AA233081)
关键词 基质金属蛋白酶9 破骨细胞 关节破坏 类风湿性关节炎 Matrix metalloproteinase-9 Osteoclast Joint destruct Rheumatoid arthritis
分类号 R967 [医药卫生—药理学]
  • 相关文献

参考文献21

  • 1Takabashi N, Akatsu T, Udagawa N, et al. Osteoblastic cells are involved in osteoclast formation[ J ]. Endocrinology, 1988,123 ( 5 ) : 2600 -2602.
  • 2Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation [ J ]. Nature ,2003,423 ( 6937 ) :337-342.
  • 3戴生明.破骨细胞的分化与激活及其在关节炎骨质破坏中的作用[J].中华风湿病学杂志,2004,8(5):312-314. 被引量：15
  • 4王晓霞,李小峰.基质金属蛋白酶与类风湿关节炎[J].中国药物与临床,2004,4(2):130-132. 被引量：4
  • 5Andersen TL, del Carmen Ovejero M, Kirkegaard T, et al. A scrutiny of matrix metalloproteinases in osteoclasts : evidence for heterogeneity and for the presence of MMPs synthesized by other cells [J]. Bone,2004,35 (5) :1107-1119.
  • 6Mort JS, Billington CJ. Articular cartilage and changes in arthritis Matrix degradation [ J ]. Arthritis Res,2001,3 ( 6 ) : 337-341.
  • 7Blavier L, Delaisse JM. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones[J]. J Cell Sci,1995,108 (12) :3649-3659.
  • 8Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks[J]. Genome Biology,2003,4(6) :216.
  • 9刘加强,杨富生.关于基质金属蛋白酶9(MMP-9)的最新进展[J].牙体牙髓牙周病学杂志,2005,15(3):168-171. 被引量：22
  • 10Wucherpfennig AL, Li YP, Stetler-Stevenson WG, et al. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts [J]. J Bone Miner Res,1994,9(4) :9549-9556.

二级参考文献52

  • 1Jones DH,Kong YY,Penninger JM.Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis,2002,61 (Suppl 2):32-39.
  • 2Khosla S.Minireview:the OPG/RANKI/RANK system. Endocrinology,2001,142:5050-5055.
  • 3Kotake S,Udagawa N,Hakoda M,et al. Activated human T cells direclly induce osteoclastogenesis from human monocytes:possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum,2001,44:1003-1012
  • 4Ziolkowska M,Kurowska M,Radzikowska A,et al. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
  • 5Takayanagi H,Iizuka H,Juji T,et al.Involvement of receptor activator of nuclear factor kappa B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.Arthritis Rheum,2000,43:259-269.
  • 6Haynes DR,Crotti TN,Loric M,et al.Osteoprotegerin and receptor activator of nuclear factor kappa B ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford),2001,40:623-630.
  • 7Kong YY,Feige U,Sarosi I,et al.Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature,1999,402:304-309.
  • 8Teitelbaum SL. Bone resorption by osteoclasts. Science,2000,289:1504-1508.
  • 9Armstrong AP,Tometsko ME, Glaccum M,et al.A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function.J Biol Chem,2002,277:44347-44356.
  • 10Mak TW,Yeh WC.Immunology:a block at the toll gate. Nature,2002,418:835-836.

共引文献38

同被引文献40

  • 1王文军,李建军,李小春,冷向阳.Ⅱ型碳酸酐酶阻断剂对体外破骨细胞的抑制作用[J].中国骨伤,2003,16(7):409-411. 被引量：2
  • 2林燕萍,周瑞祥,李异龙,袁俊,黄美雅.健骨颗粒对去卵巢骨质疏松模型鼠尿脱氧吡啶酚及骨组织整合素β_1 mRNA表达的影响[J].中国中西医结合杂志,2006,26(5):435-438. 被引量：13
  • 3庄丽,白玉兴,李俊发.龈沟液中基质金属蛋白酶-9含量与正畸牙根吸收相关性的实验研究[J].北京口腔医学,2007,15(2):65-69. 被引量：13
  • 4Aya K, Alhawagri M, Hagen-Stapleton A, et al. NF-资B inducingkinase controls lymphocyte and osteoclast activities in inflammatoryarthritis. J Clin Invest, 2005, 115(7):1848-1854.
  • 5Desai A, Darland G, Bland J S, et al. META060 attenuates TNF- a-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP- 1 in THR-lmonocytes. Athernsclerosis, 2012, 223(1): 130-136.
  • 6Yu SF, Jinjiu CY. The effect of antacids orneprazole on the osteoclastic bone resorption. Journal of Modern Stomatology, 1991,5(2) :85-87.
  • 7Supanchart C, Kornak U. Ion channels and transporters in osteoelasts. Arch Biochen Biophys,2008,473 ( 2 ) : 161-165.
  • 8Li Jj, Jing Yh, Wang H, et al. Effects of carbonic anhydrase II on osteoclustic bone resorption. Journal of Jilin University ( Medicine Edition) ,2004,301(1) : 11-13.
  • 9Baron R,Tsouderos Y. In vitro effects of S12911-2 on o steoclast function and bone marrow macrophage differentiation. Eur J Pharmaco 1,2002,450 ( 1 ) : 110-117.
  • 10Li Z, Hou WS, Esealante-Torres CR, et al. Collagenase activity of catbepsin k depends on complex fromation with chordoroitin sulfate. J Rio Chem, 2002,227 ( 32 ) : 28669 -28876.

引证文献4

二级引证文献19

医学综述
2008年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部